مؤسسة الشرق الأوسط للنشر العلمي
عادةً ما يتم الرد في غضون خمس دقائق
Background: Early prehospital assessment and timely interventions are critical determinants of survival in trauma. Emerging technologies and system innovations, including prehospital imaging, tailored resuscitation, endovascular adjuncts, and digital decision-support, are reshaping early trauma care. Methods: We performed a structured narrative review of peer-reviewed literature published between January 2018 and December 2025. PubMed and Scopus were searched using keywords related to prehospital assessment, triage, diagnostics, and early interventions. Results: Recent randomized and large observational trials support selective prehospital use of blood products (e.g., PAMPer) and prehospital plasma to reduce early mortality in selected cohorts [Sperry et al., 2018]. Prehospital ultrasound (p-FAST) improves diagnostic accuracy and shortens time to definitive care [Lucas et al., 2022], and feasibility studies demonstrate tele-supervised POCUS can extend expert interpretation to the field [Hermann et al., 2022]. Large registry data suggest REBOA may offer a survival advantage in controlled settings compared with thoracotomy, although randomized data are mixed [Cralley et al., 2023; Jansen et al., 2023]. Recent trials of prehospital TXA show mixed long-term functional benefits (PATCH-Trauma) and variable effects in smaller RCTs, arguing for selective use. Wearable sensors, AI-driven triage, drone logistics, and mobile CT show promising operational gains, but evidence for patient-level outcomes remains limited. Conclusions: Innovations in prehospital assessment and early intervention show clear potential to reduce time to diagnosis and life-saving care. However, benefits are variable depending on system capability, patient selection, and implementation logistics. Future research should prioritize controlled trials and standardized endpoints.